mTOR inhibitor WYE-28

Modify Date: 2024-01-11 22:10:41

mTOR inhibitor WYE-28 Structure
mTOR inhibitor WYE-28 structure
Common Name mTOR inhibitor WYE-28
CAS Number 1062172-60-4 Molecular Weight 586.64
Density N/A Boiling Point N/A
Molecular Formula C30H34N8O5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of mTOR inhibitor WYE-28


mTOR inhibitor WYE-28 (compound 28) is a selective inhibitor of mTOR>/b< (IC50)=0.08 nM. mTOR inhibitor WYE-28 inhibits PI3Kα with an IC50 value of 6 nM. mTOR inhibitor WYE-28 shows a metabolic time (T1/2) in nude mouse microsomes of 13 min[1].

 Names

Name mTOR inhibitor WYE-28

 mTOR inhibitor WYE-28 Biological Activity

Description mTOR inhibitor WYE-28 (compound 28) is a selective inhibitor of mTOR>/b< (IC50)=0.08 nM. mTOR inhibitor WYE-28 inhibits PI3Kα with an IC50 value of 6 nM. mTOR inhibitor WYE-28 shows a metabolic time (T1/2) in nude mouse microsomes of 13 min[1].
Related Catalog
References

[1]. Zask A, et al. ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines. J Med Chem. 2009 Aug 27;52(16):5013-6.  

 Chemical & Physical Properties

Molecular Formula C30H34N8O5
Molecular Weight 586.64
InChIKey DLIGFKRUAOAIBA-UHFFFAOYSA-N
SMILES COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)Nc5ccc(CO)cc5)cc4)nc32)CC1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
Ethanaminium, N-ethyl-N-(4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-, inner salt, sodium salt
75522-98-4
Hexa-1,5-diene;2-sulfanylethanol
75535-34-1
Hex-1-ene;2-sulfanylethanol
75535-35-2
4-((4-((Methyl-4-((2-hydroxybutyl)oxy)phenyl)azo)phenyl)amino)-3-nitro-N-(phenylsulfonyl)benzenesulfonamide, lithium salt
75627-35-9
Toxin I, entero-(Escherichia coli heat-stable reduced) 72
75661-71-1
4-((4-((Methyl-4-((2-hydroxybutyl)oxy)phenyl)azo)phenyl)amino)-3-nitro-N-(phenylsulfonyl)benzenesulfonamide, sodium salt
75684-36-5
benzene-1,4-diol;2-phenyl-1H-pyrazol-5-one;2-sulfanylacetic acid
75864-22-1
l-Cysteine, S-((acetylamino)methyl)-N-(N-(N-(N-(N-(N2-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-l-phenylalanyl)-l-phenylalanyl)-l-tryptophyl)-N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysyl)-l-threonyl)-l-phenylalanyl)-l-threonyl)-l-seryl)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester
76408-79-2
Somatostatin (sheep reduced), 1-de-l-alanine-2-deglycine-3-de-l-cysteine-4-(N2-((1,1-dimethylethoxy)carbonyl)-N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-9-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-14-(S-((acetylamino)methyl)-l-cysteine)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester
76408-86-1
Somatostatin (sheep reduced), 1-de-l-alanine-2-deglycine-3-(S-((acetylamino)methyl)-N-((1,1-dimethylethoxy)carbonyl)-l-cysteine)-4-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-9-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-14-(S-((acetylamino)methyl)-l-cysteine)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester
76408-89-4